Evidence mapPaperPMID 41555848Full record

ArticlePulmonary circulation2026

From Clusters to Outcomes: Machine Learning-Based Phenotyping in Intermediate-High-Risk Acute Pulmonary Embolism.

Barkin Kultursay, Cihangir Kaymaz, Hacer Ceren Tokgoz, Murat Karacam, Berhan Keskin, Seda Tanyeri, Aykun Hakgor, Deniz Mutlu, Cagdas Bulus, Dicle Sirma and 10 more

Abstract read
In one paragraph

Article in Pulmonary circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Barkin KultursayDepartment of Cardiology Tunceli State Hospital Tunceli Turkey.ORCID https://orcid.org/0000-0002-1424-2209
Cihangir KaymazDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Hacer Ceren TokgozDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Murat KaracamDepartment of Cardiology Bitlis State Hospital Bitlis Turkey.
Berhan KeskinDepartment of Cardiology, Faculty of Medicine Medipol University Istanbul Turkey.ORCID https://orcid.org/0000-0002-5879-2245
Seda TanyeriDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.ORCID https://orcid.org/0000-0002-0933-9233
Aykun HakgorDepartment of Cardiology, Faculty of Medicine Medipol University Istanbul Turkey.ORCID https://orcid.org/0000-0001-8252-0373
Deniz MutluDepartment of Cardiology SUNY Downstate Health Sciences University Brooklyn New York USA.ORCID https://orcid.org/0000-0003-4432-4595
Cagdas BulusDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Dicle SirmaDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Seyma Zeynep AticiDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Metehan KibarDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Seyma Nur CicekDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Aziz VezirDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Can ErdemDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Zubeyde BayramDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Seyhmus KulahciogluDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.ORCID https://orcid.org/0000-0002-6435-7821
Ahmet SekbanDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.
Ibrahim Halil TanbogaDepartment of Cardiology, Faculty of Medicine Nişantaşı University Istanbul Turkey.
Nihal OzdemirDepartment of Cardiology Kartal Kosuyolu Heart and Research Hospital Istanbul Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intermediate-high-risk (IHR) pulmonary embolism (PE) represents a heterogeneous group in whom guideline-based criteria may insufficiently capture biologic and hemodynamic variability relevant to early deterioration. Data-driven phenotyping may improve risk stratification and support individualized decisions regarding reperfusion therapy. In this retrospective cohort study (2012-2025), 553 guideline-defined IHR PE patients were analyzed using unsupervised machine learning. Thirty-six demographic, clinical, laboratory, echocardiographic, and CT variables were standardized and encoded as appropriate for clustering. Multiple algorithms were compared, and the optimal model was selected using silhouette width and stability metrics. Clinical characteristics, imaging findings, treatment patterns, and outcomes were compared across phenotypes. The primary outcome was in-hospital mortality; secondary outcome was all-cause long-term mortality. Multivariable logistic regression and Cox models assessed associations with outcomes, and pre-post-treatment changes were evaluated. Two phenotypes were identified using the k-prototypes algorithm (silhouette width = 0.697). Cluster 1 (RV-failure phenotype;

Identifiers

PMID41555848
PMCPMC12812284

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.